Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218661
Company: CIPLA
Company: CIPLA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SELENIOUS ACID | SELENIOUS ACID | EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
| SELENIOUS ACID | SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/21/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |